Synopsis
Synopsis
0
USDMF
0
JDMF
0
KDMF
0
NDC API
0
VMF
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. Depressan
2. Dihydralazine
3. Dihydrallazine
4. Dihydrazinophthalazin
5. Sulfate, Dihydralazine
1. 7327-87-9
2. Dihydralazine Sulphate
3. Depressan
4. 1,4-dihydrazinophthalazine Sulfate
5. Hydralazine Sulfate
6. 1,4-dihydrazinylphthalazine Sulfate
7. Nepresol
8. Ophthazin
9. 1,4-dihydrazinophthalazine Hydrogen Sulfate
10. (4-hydrazinylphthalazin-1-yl)hydrazine;sulfuric Acid
11. 1c2b1w91nk
12. Ophthazin Sulfate
13. Ccris 5386
14. Sulfate De Dihydralazine [french]
15. Sulfate De Dihydralazine
16. Einecs 230-808-0
17. Unii-1c2b1w91nk
18. Dihydralazinsulfat
19. Phthalazine, 1,4-dihydrazino-, Sulfate (1:1)
20. Nepresol (tn)
21. Dihydralazine Sulfate,(s)
22. Dihydralazine Hydrogen Sulfate
23. Schembl1374523
24. Chembl2106266
25. Dtxsid10223501
26. Dihydralazine Sulfate [mi]
27. Bcp11859
28. Dihydralazine For System Suitability
29. Hy-n7065
30. Mfcd00035271
31. S5030
32. Dihydralazine Sulfate [mart.]
33. Akos015960760
34. Akos037643215
35. Dihydralazine Sulfate [who-dd]
36. Ccg-267357
37. Cs-w012211
38. Sb67406
39. Ac-12152
40. As-10957
41. Ft-0731572
42. (4-hydrazinylphthalazin-1-yl)hydrazine Sulfate
43. C76337
44. D07830
45. 327d879
46. A920291
47. 1,4-dihydrazinophthalazine Hydrogen Sulphate
48. W-104459
49. Q27252218
Molecular Weight | 288.29 g/mol |
---|---|
Molecular Formula | C8H12N6O4S |
Hydrogen Bond Donor Count | 6 |
Hydrogen Bond Acceptor Count | 10 |
Rotatable Bond Count | 2 |
Exact Mass | 288.06407406 g/mol |
Monoisotopic Mass | 288.06407406 g/mol |
Topological Polar Surface Area | 185 Ų |
Heavy Atom Count | 19 |
Formal Charge | 0 |
Complexity | 248 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
Antihypertensive Agents
Drugs used in the treatment of acute or chronic vascular HYPERTENSION regardless of pharmacological mechanism. Among the antihypertensive agents are DIURETICS; (especially DIURETICS, THIAZIDE); ADRENERGIC BETA-ANTAGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCIUM CHANNEL BLOCKERS; GANGLIONIC BLOCKERS; and VASODILATOR AGENTS. (See all compounds classified as Antihypertensive Agents.)
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
Market Place
ABOUT THIS PAGE
32
PharmaCompass offers a list of Dihydralazine Sulfate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Dihydralazine Sulfate manufacturer or Dihydralazine Sulfate supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Dihydralazine Sulfate manufacturer or Dihydralazine Sulfate supplier.
PharmaCompass also assists you with knowing the Dihydralazine Sulfate API Price utilized in the formulation of products. Dihydralazine Sulfate API Price is not always fixed or binding as the Dihydralazine Sulfate Price is obtained through a variety of data sources. The Dihydralazine Sulfate Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Dihydralazine sulphate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Dihydralazine sulphate, including repackagers and relabelers. The FDA regulates Dihydralazine sulphate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Dihydralazine sulphate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Dihydralazine sulphate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Dihydralazine sulphate supplier is an individual or a company that provides Dihydralazine sulphate active pharmaceutical ingredient (API) or Dihydralazine sulphate finished formulations upon request. The Dihydralazine sulphate suppliers may include Dihydralazine sulphate API manufacturers, exporters, distributors and traders.
click here to find a list of Dihydralazine sulphate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Dihydralazine sulphate CEP of the European Pharmacopoeia monograph is often referred to as a Dihydralazine sulphate Certificate of Suitability (COS). The purpose of a Dihydralazine sulphate CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Dihydralazine sulphate EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Dihydralazine sulphate to their clients by showing that a Dihydralazine sulphate CEP has been issued for it. The manufacturer submits a Dihydralazine sulphate CEP (COS) as part of the market authorization procedure, and it takes on the role of a Dihydralazine sulphate CEP holder for the record. Additionally, the data presented in the Dihydralazine sulphate CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Dihydralazine sulphate DMF.
A Dihydralazine sulphate CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Dihydralazine sulphate CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Dihydralazine sulphate suppliers with CEP (COS) on PharmaCompass.
A Dihydralazine sulphate written confirmation (Dihydralazine sulphate WC) is an official document issued by a regulatory agency to a Dihydralazine sulphate manufacturer, verifying that the manufacturing facility of a Dihydralazine sulphate active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Dihydralazine sulphate APIs or Dihydralazine sulphate finished pharmaceutical products to another nation, regulatory agencies frequently require a Dihydralazine sulphate WC (written confirmation) as part of the regulatory process.
click here to find a list of Dihydralazine sulphate suppliers with Written Confirmation (WC) on PharmaCompass.
Dihydralazine sulphate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Dihydralazine sulphate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Dihydralazine sulphate GMP manufacturer or Dihydralazine sulphate GMP API supplier for your needs.
A Dihydralazine sulphate CoA (Certificate of Analysis) is a formal document that attests to Dihydralazine sulphate's compliance with Dihydralazine sulphate specifications and serves as a tool for batch-level quality control.
Dihydralazine sulphate CoA mostly includes findings from lab analyses of a specific batch. For each Dihydralazine sulphate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Dihydralazine sulphate may be tested according to a variety of international standards, such as European Pharmacopoeia (Dihydralazine sulphate EP), Dihydralazine sulphate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Dihydralazine sulphate USP).